OrthoPediatrics Corp Net Income (Loss) Available to Common Stockholders, Basic
OrthoPediatrics Corp (KIDS) reported Net Income (Loss) Available to Common Stockholders, Basic of -$39.65 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-03-04
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for the quarter ending 2023-12-31 was -$6.69M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for the quarter ending 2023-09-30 was -$4.59M, a 125.24% decline year-over-year.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for the quarter ending 2022-12-31 was -$7.70M, a 10790.28% decline year-over-year.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was $18.19M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for fiscal 2025 was -$39.65M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for fiscal 2024 was -$37.82M.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for fiscal 2023 was -$20.97M, a 1798.30% decline from fiscal 2022.
- OrthoPediatrics Corp net income (loss) available to common stockholders, basic for fiscal 2022 was $1.24M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$39.65M 10-K · filed 2026-03-04 | |||
| 2024-12-31 | -$37.82M 10-K · filed 2026-03-04 | |||
| 2023-12-31 | -$6.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$11.28M derived: sum of 2 quarters · filed 2026-03-04 | -$20.97M 10-K · filed 2026-03-04 | |
| 2023-09-30 | -$4.59M 10-Q · filed 2023-11-07 | -$14.28M 10-Q · filed 2023-11-07 | ||
| 2022-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $10.49M derived: sum of 2 quarters · filed 2025-03-05 | $1.24M 10-K · filed 2025-03-05 | |
| 2022-09-30 | $18.19M 10-Q · filed 2023-11-07 | $8.93M 10-Q · filed 2023-11-07 | ||
| 2021-12-31 | $72.00K 10-K · filed 2022-03-03 | -$2.13M derived: sum of 2 quarters · filed 2022-11-01 | -$5.88M derived: sum of 3 quarters · filed 2022-11-01 | -$16.26M 10-K · filed 2024-03-08 |
| 2021-09-30 | -$2.20M 10-Q · filed 2022-11-01 | -$5.95M derived: sum of 2 quarters · filed 2022-11-01 | -$16.33M 10-Q · filed 2022-11-01 | -$30.34M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$3.76M 10-K · filed 2022-03-03 | -$14.13M derived: sum of 2 quarters · filed 2022-03-03 | -$28.15M derived: sum of 3 quarters · filed 2022-03-03 | -$32.69M derived: sum of 4 quarters · filed 2022-03-03 |
| 2021-03-31 | -$10.38M 10-K · filed 2022-03-03 | -$24.39M derived: sum of 2 quarters · filed 2022-03-03 | -$28.93M derived: sum of 3 quarters · filed 2022-03-03 | -$38.38M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-12-31 | -$14.01M 10-K · filed 2022-03-03 | -$18.55M derived: sum of 2 quarters · filed 2022-03-03 | -$28.00M derived: sum of 3 quarters · filed 2022-03-03 | -$32.94M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$4.54M 10-K · filed 2022-03-03 | -$13.99M derived: sum of 2 quarters · filed 2022-03-03 | -$18.93M 10-Q · filed 2020-11-05 | -$24.36M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | -$9.45M 10-K · filed 2022-03-03 | -$14.39M 10-Q · filed 2020-08-06 | -$19.82M derived: sum of 3 quarters · filed 2022-03-03 | -$22.48M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | -$4.95M 10-K · filed 2022-03-03 | -$10.37M derived: sum of 2 quarters · filed 2022-03-03 | -$13.04M derived: sum of 3 quarters · filed 2022-03-03 | -$15.66M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | -$5.43M 10-K · filed 2021-03-11 | -$8.09M derived: sum of 2 quarters · filed 2021-03-11 | -$10.71M derived: sum of 3 quarters · filed 2021-03-11 | -$13.73M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$2.66M 10-K · filed 2021-03-11 | -$5.28M derived: sum of 2 quarters · filed 2021-03-11 | -$8.30M 10-Q · filed 2020-11-05 | -$10.77M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | -$2.62M 10-K · filed 2021-03-11 | -$5.64M 10-Q · filed 2020-08-06 | -$8.11M derived: sum of 3 quarters · filed 2021-03-11 | -$9.97M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$3.02M 10-K · filed 2021-03-11 | -$5.49M derived: sum of 2 quarters · filed 2021-03-11 | -$7.35M derived: sum of 3 quarters · filed 2021-03-11 | -$10.04M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | -$2.47M 10-K · filed 2020-03-05 | -$4.33M derived: sum of 2 quarters · filed 2020-03-05 | -$7.03M derived: sum of 3 quarters · filed 2020-03-05 | -$12.03M 10-K · filed 2021-03-11 |
| 2018-09-30 | -$1.86M 10-K · filed 2020-03-05 | -$4.56M derived: sum of 2 quarters · filed 2020-03-05 | -$9.56M 10-Q · filed 2019-11-08 | -$24.64M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | -$2.69M 10-K · filed 2020-03-05 | -$7.69M 10-Q · filed 2019-08-13 | -$22.77M derived: sum of 3 quarters · filed 2020-03-05 | -$25.79M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | -$5.00M 10-K · filed 2020-03-05 | -$20.08M derived: sum of 2 quarters · filed 2020-03-05 | -$23.10M derived: sum of 3 quarters · filed 2020-03-05 | -$25.82M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | -$15.08M 10-K · filed 2019-03-07 | -$18.10M derived: sum of 2 quarters · filed 2019-03-07 | -$20.82M derived: sum of 3 quarters · filed 2019-03-07 | -$23.53M 10-K · filed 2020-03-05 |
| 2017-09-30 | -$3.02M 10-K · filed 2019-03-07 | -$5.74M derived: sum of 2 quarters · filed 2019-03-07 | -$8.45M 10-Q · filed 2018-10-31 | -$13.74M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$2.72M 10-K · filed 2019-03-07 | -$5.43M 10-Q · filed 2018-08-09 | -$10.72M derived: sum of 3 quarters · filed 2019-03-07 | -$13.13M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$2.71M 10-K · filed 2019-03-07 | -$8.00M derived: sum of 2 quarters · filed 2019-03-07 | -$10.40M derived: sum of 3 quarters · filed 2019-03-07 | -$12.09M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$5.29M 10-K · filed 2018-03-15 | -$7.69M derived: sum of 2 quarters · filed 2018-03-15 | -$9.38M derived: sum of 3 quarters · filed 2018-03-15 | -$12.45M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$2.40M 10-K · filed 2018-03-15 | -$4.09M derived: sum of 2 quarters · filed 2018-03-15 | -$7.23M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$1.69M 10-K · filed 2018-03-15 | -$4.75M derived: sum of 2 quarters · filed 2018-03-15 | ||
| 2016-03-31 | -$3.07M 10-K · filed 2018-03-15 | |||
| 2015-12-31 | -$12.69M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |